Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia

Disease-modifying therapies (DMT) for relapsing-remitting MS (RRMS) act on the immune system, suggesting a need for caution during the SARS-CoV2/Covid-19 pandemic. A group of experts in MS care from Saudi Arabia convened to consider the impact of Covid-19 on MS care in that country, and to develop c...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mult Scler Relat Disord
Autori principali: Al Jumah, Mohammed, Abulaban, Ahmad, Aggad, Hani, Al Bunyan, Reem, AlKhawajah, Mona, Al Malik, Yaser, Almejally, Mousa, Alnajashi, Hind, Alshamrani, Foziah, Bohlega, Saeed, Cupler, Edward J, ElBoghdady, Ahmed, Makkawi, Seraj, Qureshi, Shireen, Shami, Sahar
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Authors. Published by Elsevier B.V. 2021
Soggetti:
Review Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7992311/
https://ncbi.nlm.nih.gov/pubmed/33857897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2021.102925
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi